Generation of a human induced pluripotent stem cell (iPSC) line from a patient carrying a P33T mutation in the PDX1 gene

Xianming Wang, Shen Chen, Ingo Burtscher, Michael Sterr, Anja Hieronimus, Fausto Machicao, Harald Staiger, Hans Ulrich Häring, Gabriele Lederer, Thomas Meitinger, Heiko Lickert

Publikation: Beitrag in FachzeitschriftArtikelBegutachtung

13 Zitate (Scopus)

Abstract

Homozygous loss-of-function mutations in the gene coding for the homeobox transcription factor PDX1 leads to pancreatic agenesis, whereas certain heterozygous point mutations are associated with Maturity-Onset Diabetes of the Young 4 (MODY4) and Type 2 Diabetes Mellitus (T2DM). To understand the pathomechanism of MODY4 and T2DM, we have generated iPSCs from a woman with a P33T heterozygous mutation in the transactivation domain of PDX1. The resulting PDX1 P33T iPSCs generated by episomal reprogramming are integration-free, have a normal karyotype and are pluripotent in vitro and in vivo. Taken together, this iPSC line will be useful to study diabetes pathomechanisms.

OriginalspracheEnglisch
Seiten (von - bis)273-276
Seitenumfang4
FachzeitschriftStem Cell Research
Jahrgang17
Ausgabenummer2
DOIs
PublikationsstatusVeröffentlicht - Sept. 2016

Fingerprint

Untersuchen Sie die Forschungsthemen von „Generation of a human induced pluripotent stem cell (iPSC) line from a patient carrying a P33T mutation in the PDX1 gene“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren